Top 6 Companies in the Global Virus Filtration Market in 2025

The global virus filtration market was valued at USD 5.17 billion in 2024. The market is expected to grow at a CAGR of 12.30% during the forecast period of 2025-2034, with the values likely to reach USD 16.49 billion by 2034. The market is driven by advances in filtration technologies and growing global concerns about viral contamination.

Virus filtration is an essential process used to eliminate viral contaminants from biological materials, such as vaccines, therapeutic proteins, and cell culture media. It employs specialized filters, that are designed to trap viruses while allowing the desired substances to pass through. These filters are highly effective at removing harmful viruses, including retroviruses, adenoviruses, and parvoviruses. It also plays a vital role in protecting public health from potential viral infections, by enhancing the quality of products.

The global virus filtration market is experiencing significant growth due to the increasing demand for biologics and biopharmaceuticals. The key drivers of the market include advancements in filtration technologies, heightened regulatory pressures, and growing concerns about viral contamination in vaccines and therapeutic products. The market is further supported by the rising awareness about product safety, stringent quality control regulations, and the adoption of single-use technologies. Additionally, the trend toward biologics and personalized medicine is boosting the demand for effective virus filtration solutions across multiple applications.

In October 2024, Asahi Kasei Medical launched the Planova FG1, a next-generation virus removal filter aimed at enhancing productivity in biopharmaceutical manufacturing. The product features a high flux rate, which reduces the filtration time and minimizes the risk of virus breakthrough. This launch supports the increasing demand for monoclonal antibodies and biopharmaceuticals, which is expected to grow by 5% to 10% annually and contribute to market expansion.

Leading companies in the global virus filtration market in 2025

1.    Sartorius AG

Sartorius AG is a leading laboratory filtration solutions provider that specializes in ultrafiltration products for industries, including biotechnology and pharmaceuticals. Their Vivaspin and Vivaflow series ultrafilters are essential for concentrating proteins, nucleic acids, viruses, and other macromolecules. By offering high-performance filtration systems that support virus concentration, pathogen isolation, and diagnostic sample preparation, the company plays a significant role in the growth of the virus filtration market. Moreover, Sartorius's advanced technologies contribute to faster processing times and improved recovery rates.

2.    Asahi Kasei Medical Co. Ltd

Asahi Kasei Medical is a significant player in the market that specializes in advanced filtration technologies to produce biopharmaceuticals. Their Planova virus removal filters, including Planova FG1, are designed to enhance the safety and efficiency of biotherapeutic manufacturing. The Planova™ FG1 is characterized by its excellent flux, which reduces the filtration time while effectively eliminating viruses. By prioritizing continuous product innovation, the company continues to address the increasing demand for high-quality, safe biopharmaceuticals, thus strengthening its market presence.

3.    Qiagen NV

QIAGEN is a prominent player specializing in molecular biology and diagnostics. It offers advanced solutions for the extraction of DNA, RNA, and proteins. One of its flagship products in virus filtration is QIAamp MinElute Virus Kit, which isolates viral DNA and RNA from plasma, serum, and other cell-free fluids. This kit is known for its high sensitivity in PCR applications, making it a crucial tool in viral diagnostics and research on infectious diseases. Their innovative technology continues to drive advancements in the virus filtration market, enhancing both efficiency and accuracy.

4.    Pall Corporation

Pall Corporation is a leading provider of filtration, separation, and purification technologies, offering solutions across a range of industries, including healthcare and aerospace. The company plays a significant role in the global virus filtration market with its high-efficiency HEPA filters, which can remove more than 99.999% of bacteria and viruses. Their products are essential for maintaining safety and cleanliness in critical environments, such as medical and aerospace applications. By supplying reliable filtration systems, Pall contributes to market growth, enhances product integrity, and addresses the increasing demands for contamination control.

5.    Merck KgaA

Merck, known as MilliporeSigma in the United States and Canada, is a key player in the global market for virus filtration. One of its key products is Viresolve Pro Solution, which is a high-performance viral clearance technology specifically designed for biologics manufacturing. This solution offers excellent virus retention and effective parvovirus clearance. With the Viresolve® Pro Device, it achieves a ≥4.0 log removal of parvovirus and maintains its effectiveness even during process interruptions. Additionally, Merck’s innovative solutions, such as the Viresolve Pro Shield prefilters, enhance throughput and processing efficiency, emphasizing their position in the market. Their extensive expertise supports viral safety across various industries, advancing the field of virus filtration worldwide.

6.    General Electric Company

GE Healthcare is a leading global provider of healthcare technologies and offers a wide range of products and services, including virus filtration solutions. Their heat and moisture exchange filters (HMEFs) and viral filters are specifically designed to prevent cross-contamination during medical procedures, such as anesthesia and ventilation. These filters are engineered to capture airborne particles while providing high-efficiency bacterial and viral filtration.